The global skincare industry has witnessed a remarkable shift toward natural and plant-based ingredients over the past decade. Botanical extracts for skin care products — from aloe vera and green tea to centella asiatica and licorice root — are now staples in formulations ranging from luxury serums to mass-market moisturizers. However, with this growing demand comes an increasingly complex regulatory landscape. Whether you are a cosmetic brand, a formulator, or a botanical extract manufacturer, understanding the regulatory requirements governing botanical extracts in skincare products is essential for market access, consumer safety, and long-term business success.

This article provides a comprehensive overview of the key regulatory frameworks in major markets — the United States, the European ｕｎｉｏｎ, and China — and outlines the practical steps brands and suppliers must take to ensure compliance when using botanical extracts for cosmetics and personal care products.

1. United States: FDA and MoCRA

In the United States, the Food and Drug Administration (FDA) regulates cosmetics under the Federal Food, Drug, and Cosmetic Act (FD&C Act). The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) — the most significant ｕｐｄａｔｅ to U.S. cosmetics law since 1938 — introduced several new requirements that directly affect companies using botanical extracts in skincare formulations.

Facility Registration and Product Listing

Under MoCRA, every facility that manufactures or processes cosmetic products for distribution in the United States must register with the FDA and renew that registration biennially. Additionally, a "responsible person" — typically the manufacturer, packer, or distributor whose name appears on the product label — must list each marketed cosmetic product with the FDA, including its ingredients. This means every botanical extract used in a formula must be accurately declared as part of the product listing.

Safety Substantiation

MoCRA explicitly requires that a responsible person ensure and maintain records supporting adequate safety substantiation for each cosmetic product. While the FDA does not mandate specific tests, the safety data must be derived from scientifically robust methods. For botanical extracts, this typically involves:

• Toxicological profiles of the botanical source material
• Heavy metal, pesticide residue, and microbial testing of the extract
• Skin irritation and sensitization patch testing
• Stability data confirming the extract's integrity within the final formulation

Adverse Event Reporting and GMP

Serious adverse events associated with cosmetic use must be reported to the FDA within 15 business days. MoCRA also requires the FDA to establish Good Manufacturing Practice (GMP) regulations for cosmetic facilities — a draft guidance has been published, and companies working with botanical extracts should proactively align their manufacturing and quality control processes with these emerging standards.

2. European ｕｎｉｏｎ: EU Cosmetic Regulation (EC) No. 1223/2009

The European ｕｎｉｏｎ operates one of the world's most stringent regulatory frameworks for cosmetics. Unlike the U.S. approach, the EU requires a mandatory pre-market safety assessment for every cosmetic product placed on the market.

The Cosmetic Product Safety Report (CPSR)

Under the EU Cosmetics Regulation, a "responsible person" must ensure that a Cosmetic Product Safety Report (CPSR) is prepared before the product is placed on the market. The CPSR consists of two parts:

• Part A — Cosmetic Product Safety Information: Includes quantitative and qualitative composition, physical/chemical characteristics, stability, microbiological quality, impurities and traces, and a toxicological profile of each ingredient, including botanical extracts.
• Part B — Cosmetic Product Safety Assessment: A signed assessment by a qualified safety assessor concluding whether the product is safe under normal and reasonably foreseeable use.

Restricted and Prohibited Substances

The EU Cosmetic Regulation maintains a negative list of prohibited substances and a restricted list for substances that may be used only under specified conditions. Certain botanical extracts — such as those from plants classified as endangered under CITES, or those containing known sensitizers or phototoxic compounds — may be restricted or banned. For example, the Scientific Committee on Consumer Safety (SCCS) has issued specific opinions on botanical ingredients like tea tree oil, setting maximum safe concentrations for use in cosmetic products.

Microbiological Quality

The EU regulation requires microbial challenge testing per ISO 11930:2019. Botanical extracts, being natural products, can be particularly susceptible to microbial contamination. Suppliers should provide certificates of analysis demonstrating compliance with microbiological limits as specified in the European Pharmacopoeia.

3. China: NMPA and the IECIC

China has rapidly developed into one of the world's largest cosmetics markets, and its regulatory framework — overseen by the National Medical Products Administration (NMPA) — has evolved significantly. The Cosmetics Supervision and Administration Regulation (CSAR), effective since 2021, introduced a comprehensive regulatory system.

Inventory of Existing Cosmetic Ingredients in China (IECIC)

China operates a positive-list system for cosmetic ingredients. The IECIC lists all permitted cosmetic ingredients, including plant extracts. Any botanical extract used in a cosmetic product sold in China must appear on the IECIC. If an extract is not listed, it must be registered as a New Cosmetic Ingredient (NCI), which requires a full safety dossier. This is a critical consideration for brands looking to introduce novel botanical ingredients into the Chinese market.

Notified vs. Registered Cosmetics

General cosmetics (non-special-use) must be filed with the NMPA by a domestic responsible person or a domestic agent for imported products. Special-use cosmetics — including sunscreens, hair dyes, and skin-whitening products — require pre-market registration and a more extensive safety evaluation. Botanical extracts used in special-use formulations must meet additional scrutiny.

4. Key Compliance Focus Areas for Botanical Extracts

Purity and Contaminant Control

Botanical extracts, being derived from natural plant sources, are inherently variable. Regulators across all major markets expect manufacturers to demonstrate consistent control over:

• Heavy metals: Lead, arsenic, mercury, and cadmium levels must comply with the ICH Q3D guidelines or applicable pharmacopoeia limits.
• Pesticide residues: Compliance with pharmacopoeia requirements or EU Regulation (EC) No. 396/2005 maximum residue levels.
• Solvent residues: Residual solvents from extraction processes must be controlled per pharmacopoeia standards.
• Microbial limits: Total aerobic microbial count, yeast and mold, and absence of specified pathogens.

Standardization and Active Compound Verification

Regulatory bodies increasingly expect botanical extracts to be standardized to specific active marker compounds. For example, a green tea extract should be standardized to a defined percentage of polyphenols or EGCG, and a ginkgo biloba extract should meet defined flavonoid glycoside and terpene lactone levels. This standardization ensures batch-to-batch consistency and supports safety substantiation by providing a reproducible chemical profile.

Stability and Compatibility Testing

Botanical extracts can interact with other formulation components — emulsifiers, preservatives, fragrances — in ways that affect product stability and safety. Accelerated and real-time stability studies should be conducted on the final formulation, not just the individual extract. Photostability testing is particularly important for botanical ingredients that may degrade under UV exposure.

5. Choosing a Compliant Botanical Extract Supplier

Given the regulatory complexity, cosmetic brands and formulators should carefully evaluate their botanical extract suppliers. Key criteria include:

• Comprehensive documentation: The supplier should provide a full technical data package including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS/SDS), specification sheets, and stability data for each batch.
• Third-party testing: Independent laboratory verification of purity, potency, and contaminant levels adds a layer of credibility.
• Regulatory expertise: A supplier familiar with the regulatory requirements of your target markets can help anticipate and address compliance issues before they become problems.
• Traceability: Full traceability from raw botanical source to finished extract — including country of origin, harvest date, extraction method, and processing history — is increasingly expected by regulators and consumers alike.
• Quality certifications: ISO 9001, GMP compliance, Halal, Kosher, and organic certifications (USDA NOP, EU Organic) indicate a supplier's commitment to quality management.

Botaniex, a botanical extract manufacturer based in Changsha, China, provides standardized botanical extracts with comprehensive quality documentation to support the regulatory compliance needs of cosmetic brands worldwide. With advanced extraction capabilities — including water, alcohol, and supercritical CO₂ extraction — and a rigorous quality control program that covers raw material authentication, active compound verification, and microbial testing, the company serves clients across North America, Europe, and Asia.

Conclusion

Navigating the regulatory requirements for botanical extracts in skincare products requires a thorough understanding of the applicable frameworks in each target market. In the United States, MoCRA has elevated the bar for facility registration, product listing, safety substantiation, and adverse event reporting. In the European ｕｎｉｏｎ, the mandatory CPSR and the careful scrutiny of restricted substances demand rigorous pre-market preparation. In China, the IECIC positive-list system and CSAR add another layer of complexity for brands entering the Asian market.

For cosmetic brands and formulators, the path to compliance starts with selecting a botanical extract supplier that provides complete documentation, consistent quality, and regulatory expertise. By partnering with an experienced manufacturer that understands global regulatory demands, brands can focus on innovation and market growth while maintaining full confidence in the safety and compliance of their botanical skincare formulations.